Teva CEO touts 'defining strength' of innovative drugs as its sales grow for 11th straight quarter

5th November 2025 Uncategorised 0

The company remains confident in the continued sales potential of Austedo after wrapping up government negotiations that will change the Medicare price for its top-seller in 2027.

More: Teva CEO touts 'defining strength' of innovative drugs as its sales grow for 11th straight quarter
Source: fierce